Cargando…

FK506 attenuates thymic output in patients with myasthenia gravis

INTRODUCTION: Myasthenia gravis (MG) is an antibody-mediated, T-cell-dependent autoimmune disease. The symptoms are caused by high-affinity IgG against the muscle acetylcholine receptor (AChR) at the neuromuscular junction. The production of these antibodies in B-cells depends on AChR-specific CD4(+...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mitsui, Takao, Kuroda, Yukiko, Ueno, Shu-ichi, Matsui, Naoko, Kaji, Ryuji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2013
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3902727/ https://www.ncbi.nlm.nih.gov/pubmed/24482655 http://dx.doi.org/10.5114/aoms.2013.39797

Ejemplares similares

Late-onset myasthenia gravis is predisposed to become generalized in the elderly
por: Sakai, Waka, et al.
Publicado: (2016)

Interactions of FK506 and Rapamycin With FK506 Binding Protein 12 in Opportunistic Human Fungal Pathogens
por: Vellanki, Sandeep, et al.
Publicado: (2020)

Maculopathy Associated with Tacrolimus (FK 506)
por: Koh, Taehyuk, et al.
Publicado: (2011)

The immunosuppressive and toxic effects of FK-506 are mechanistically related: pharmacology of a novel antagonist of FK-506 and rapamycin
Publicado: (1992)

FK506 Attenuated Pilocarpine-Induced Epilepsy by Reducing Inflammation in Rats
por: Wang, Aihua, et al.
Publicado: (2019)

Intrathymic Plasmablasts Are Affected in Patients With Myasthenia Gravis With Active Disease
por: Yamamoto, Yohei, et al.
Publicado: (2021)

Treatment With Calcineurin Inhibitor FK506 Attenuates Noise-Induced Hearing Loss
por: He, Zu-Hong, et al.
Publicado: (2021)

Pathologic Finding of Thymic Carcinoma Accompanied by Myasthenia Gravis
por: Kim, Se Hoon, et al.
Publicado: (2015)

Thymic carcinoma with myasthenia gravis: Two case reports
por: Kurihara, Nobuyasu, et al.
Publicado: (2016)

Somatic mutations of thymic epithelial tumors with myasthenia gravis
por: Pardini, Eleonora, et al.
Publicado: (2023)

Localized Thymic Amyloidosis Presenting with Myasthenia Gravis: Case Report
por: Son, Seung-Myoung, et al.
Publicado: (2014)

Myasthenia Gravis Related to Thymic Carcinoma: A Case Study
por: Lopes, Daniel Thomas Pereira, et al.
Publicado: (2020)

The Effect of FK 506 on the Reepithelialization of Superficial Skin Wound
por: Shin, Jeong Min, et al.
Publicado: (2017)

FK506 Attenuates the MRP1-Mediated Chemoresistant Phenotype in Glioblastoma Stem-Like Cells
por: Torres, Ángelo, et al.
Publicado: (2018)

Comparative Analysis of Thymic and Blood Treg in Myasthenia Gravis: Thymic Epithelial Cells Contribute to Thymic Immunoregulatory Defects
por: Truffault, Frédérique, et al.
Publicado: (2020)

Updates in CT characterization of thymic epithelial tumors in patients with myasthenia gravis
por: Popa, GA, et al.
Publicado: (2012)

Blocking interleukin-23 ameliorates neuromuscular and thymic defects in myasthenia gravis
por: Villegas, José A., et al.
Publicado: (2023)

Effects of FK506 on Ca(2+) Release Channels (Review)
por: Ozawa, Terutaka
Publicado: (2008)

Molecular Evolution of the Vertebrate FK506 Binding Protein 25
por: Liu, Fei, et al.
Publicado: (2014)

FK506 immunosuppression for submandibular salivary gland allotransplantation in rabbit
por: Almansoori, Akram Abdo, et al.
Publicado: (2020)

Role of FK506-sensitive signals in asthmatic lung inflammation
por: Tomiaki, Chihiro, et al.
Publicado: (2022)

FK506-Binding Protein 2 Participates in Proinsulin Folding
por: Hoefner, Carolin, et al.
Publicado: (2023)

49. Recruited Macrophages are Required for Neuroenhancing Effects of Fk506
por: Broberg, Curtis, et al.
Publicado: (2023)

Advancing Nerve Regeneration: Translational Perspectives of Tacrolimus (FK506)
por: Daeschler, Simeon C., et al.
Publicado: (2023)

FK506-binding protein-like and FK506-binding protein 8 regulate dual leucine zipper kinase degradation and neuronal responses to axon injury
por: Lee, Bohm, et al.
Publicado: (2022)

Emergence of Myasthenia Gravis with Myositis in a Patient Treated with Pembrolizumab for Thymic Cancer
por: Huh, So-Young, et al.
Publicado: (2018)

An improved reversibly dimerizing mutant of the FK506-binding protein FKBP
por: Barrero, Juan J., et al.
Publicado: (2016)

Abstract 134: FK506 Delivering Conduit For Peripheral Nerve Regeneration
por: Labroo, Pratima, et al.
Publicado: (2017)

Targeted Covalent Inhibition of Plasmodium FK506 Binding Protein 35
por: Atack, Thomas C., et al.
Publicado: (2020)

FK506 increases susceptibility to musculoskeletal infection in a rodent model
por: Shiels, Stefanie M., et al.
Publicado: (2022)

Optimization of the precursor supply for an enhanced FK506 production in Streptomyces tsukubaensis
por: Schulz, Susann, et al.
Publicado: (2022)

Development of Non-Immunosuppressive FK506 Derivatives as Antifungal and Neurotrophic Agents
por: Jung, Jin A, et al.
Publicado: (2020)

Lower Urinary Tract Symptoms in Myasthenia Gravis
por: Tateno, Fuyuki, et al.
Publicado: (2021)

Administration of FK506 from Late Stage of Disease Prolongs Survival of Human Prion-Inoculated Mice
por: Nakagaki, Takehiro, et al.
Publicado: (2020)

Myasthenia gravis
por: Juel, Vern C, et al.
Publicado: (2007)

Myasthenia Gravis
por: Aarli, Johan A., et al.
Publicado: (2011)

Myasthenia Gravis
Publicado: (1905)

Myasthenia Gravis
por: Wilson, Andrew
Publicado: (1952)

Myasthenia Gravis
por: Bramwell, Edwin
Publicado: (1901)

Pathogenetic Significance of Fetal-Type Acetylcholine Receptors on Thymic Myoid Cells in Myasthenia Gravis
por: Geuder, Kerstin I., et al.
Publicado: (1992)

Cannot write session to /tmp/vufind_sessions/sess_gov62di69a25fdfq1o7lldpf98